Radio and PodcastLive Radio & PodcastsScience & Medicine
106 - Bright Spot Among CRISPR in Caribou Biosci. 2022 Biotech Trends to Watch!
CRISPR is an exciting space, with a number of companies finally sharing early clinical data in 2021. NTLA benefitted the most from this by doubling in valuation after data release, while the other CRISPR companies contin...
About This Episode
106 - Bright Spot Among CRISPR in Caribou Biosci. 2022 Biotech Trends to Watch! is an episode from Breaking Biotech by Matthew Lepoire. CRISPR is an exciting space, with a number of companies finally sharing early clinical data in 2021. NTL...
Podcast
This episode belongs to Breaking Biotech.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Jan 9, 2022, 00:42:53 long, audio available.
Related Episodes
Continue listening to more episodes from Breaking Biotech.
112 - Biotech Updates - $BTAI $TGTX $CRIS $CKPT $KPTI $SRRA
Apr 21, 2022 - 00:43:59
111 - Achieve Life Sciences Phase 3 Readout Imminent! Interview with CEO John Bencich
Apr 1, 2022 - 00:28:19
109 - Karyopharm Guides INCREASED Sales Growth in 2022 and Reports Positive SIENDO Results
Feb 22, 2022 - 00:33:42
108 - NASH Companies to Watch in 2022! Madrigal Pharma Announces Positive Data in NAFLD
Feb 7, 2022 - 00:37:28